LOMAX
Price
$15.86
Change
+$0.06 (+0.38%)
Updated
Jul 3 closing price
Net Assets
98.48M
VIVIX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

LOMAX vs VIVIX

Header iconLOMAX vs VIVIX Comparison
Open Charts LOMAX vs VIVIXBanner chart's image
Edgar Lomax Value
Price$15.86
Change+$0.06 (+0.38%)
VolumeN/A
Net Assets98.48M
Vanguard Value Index I
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
LOMAX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LOMAX vs. VIVIX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LOMAX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. LOMAX (98.5M). LOMAX pays higher dividends than VIVIX: LOMAX (2.86) vs VIVIX (2.19). LOMAX was incepted earlier than VIVIX: LOMAX (28 years) vs VIVIX (27 years). LOMAX (1.00) is less costly to investors than VIVIX (0.04). LOMAX is a more actively managed with annual turnover of: 30.46 vs. VIVIX (9.00). LOMAX has a lower initial minimum investment than VIVIX: LOMAX (2500) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 12.05 vs. LOMAX (11.38). VIVIX return over 5 years is better than : 80.14 vs. LOMAX (46.81).
LOMAXVIVIXLOMAX / VIVIX
Total Expense Ratio0.710.041,775%
Annual Report Gross Expense Ratio1.000.042,500%
Fund Existence28 years27 years-
Gain YTD9.3046.215150%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets98.5M189B0%
Annual Yield % from dividends2.862.19131%
Returns for 1 year11.3812.0594%
Returns for 3 years11.6135.1733%
Returns for 5 years46.8180.1458%
Returns for 10 years39.57115.6834%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOPX36.410.36
+1.00%
Patient Opportunity C
VYSGX14.890.14
+0.95%
Voya Small Company W
ESCGX11.650.11
+0.95%
Ashmore Emerging Markets Equity ESG C
ARAFX11.800.02
+0.17%
Aristotle International Eq A
TREPX15.63-0.02
-0.13%
Nuveen International Eq Premier